NorthWest Biotherapeutics Inc (NWBO)

[reachjo]

Here is a bigger problem with using Boockvar as a reference for what works. John Boockvar is the CEO of EnterTroy Bio, a company dedicated to finding ways to increase the permeability of the blood brain barrier to treat brain cancer. By increasing permeability of the blood brain barrier, drugs like Avastin have a better chance of getting in. If DCVax works, that company is in serious trouble. Hence, Dr. Boockvar has a vested interested promoting EnterTroy’s treatment approach. In this case he is not a credible source due to conflict of interest.

I could go on, but I think my point is made. DCVax threatens the very fabric of the entire cancer industry, from practicing surgeons to radiation/chemo to companies like Dr. Boockvar. It’s applications are across all cancers and beyond. If DCVax works, which data presented in 2018 is showing, the whole industry is going to turned upside down and many companies will fold to the tune of tens of billions of dollars. They are going to fight tooth and nail to stop this from happening. The truth is, the fight for NWBO will start when TLD is released and stock rises. Manipulating a few pennies is painful, but when that turns into dollars it will be torture. The tactics investment houses and big pharma/bio are going to throw at NWBO to manipulate our stock will be unrelenting. To every long who has hung in there you have my deepest respect and please continue to do so. Stay strong, stay long. The availability of the best treatment for GBM rests with your faith.